Picture of Ayala Pharmaceuticals logo

ADXS Ayala Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Advaxis Reports Qtrly Loss Per Share $1

Sept 9 (Reuters) - Advaxis Inc  ADXS.O :
    * ADVAXIS REPORTS FISCAL THIRD QUARTER 2019 FINANCIAL
RESULTS AND
PROVIDES PIPELINE UPDATE
    * ADVAXIS INC - AS OF JULY 31, CO HAD APPROXIMATELY $41.8
MILLION
IN CASH & CASH EQUIVALENTS
    * ADVAXIS INC - CO BELIEVES CAPITAL IS SUFFICIENT TO FUND
OBLIGATIONS UNTIL AT LEAST SEPTEMBER 2020
    * ADVAXIS INC QTRLY REVENUE $6000 VERSUS $1.1 MILLION
    * ADVAXIS INC QTRLY LOSS PER SHARE $1

Source text for Eikon:  ID:nBwbSwLMda 
Further company coverage:  ADXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ayala Pharmaceuticals

See all news